Your session is about to expire
← Back to Search
Leflunomide for Chronic Graft Versus Host Disease
Study Summary
This trial is studying leflunomide to see if it can help patients with cGVHD who have not responded to steroids.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 400 Patients • NCT01172639Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many participants are invited to join this medical examination?
"Indeed, records on clinicaltrials.gov show that this medical investigation is presently recruiting for 24 volunteers across a single hospital. The trial was first posted in May 12th 2020 and its most recent update took place September 14th 2022."
Can you tell me what prior investigations have been conducted with Leflunomide?
"As of now, 15 experiments related to leflunomide are active with 2 trials in the advanced stage 3. Most research is conducted in Duarte, California; however, 22 clinical trial sites participate across the nation."
Does this trial have availability for new participants?
"According to clinicaltrials.gov, this trial is currently welcoming participants and was first made public on the 12th of May 2020 with its most recent revision on September 14th 2022."
How secure is the utilization of leflunomide for therapeutic purposes?
"As this is an early stage trial with limited evidence for safety and efficacy, leflunomide was rated a 1 on our scale at Power."
Share this study with friends
Copy Link
Messenger